Logo image of BNFT

BENEFITFOCUS INC (BNFT) Stock Fundamental Analysis

NASDAQ:BNFT - Nasdaq - US08180D1063 - Common Stock - Currency: USD

10.5  +0.01 (+0.1%)

After market: 10.5 0 (0%)

Fundamental Rating

2

Taking everything into account, BNFT scores 2 out of 10 in our fundamental rating. BNFT was compared to 282 industry peers in the Software industry. BNFT may be in some trouble as it scores bad on both profitability and health. BNFT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

BNFT had positive earnings in the past year.
BNFT had a positive operating cash flow in the past year.
BNFT Yearly Net Income VS EBIT VS OCF VS FCFBNFT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M -40M -60M

1.2 Ratios

The profitability ratios for BNFT are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BNFT Yearly ROA, ROE, ROICBNFT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 500 -500 -1K

1.3 Margins

Looking at the Gross Margin, with a value of 50.35%, BNFT is doing worse than 69.10% of the companies in the same industry.
In the last couple of years the Gross Margin of BNFT has grown nicely.
The Profit Margin and Operating Margin are not available for BNFT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.18%
GM growth 5Y2.2%
BNFT Yearly Profit, Operating, Gross MarginsBNFT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

BNFT does not have a ROIC to compare to the WACC, probably because it is not profitable.
BNFT has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, BNFT has an improved debt to assets ratio.
BNFT Yearly Shares OutstandingBNFT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M
BNFT Yearly Total Debt VS Total AssetsBNFT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -0.99, we must say that BNFT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.99, BNFT is not doing good in the industry: 80.07% of the companies in the same industry are doing better.
BNFT has a debt to FCF ratio of 65.75. This is a negative value and a sign of low solvency as BNFT would need 65.75 years to pay back of all of its debts.
With a Debt to FCF ratio value of 65.75, BNFT perfoms like the industry average, outperforming 59.80% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 65.75
Altman-Z -0.99
ROIC/WACCN/A
WACC10.98%
BNFT Yearly LT Debt VS Equity VS FCFBNFT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M 200M

2.3 Liquidity

A Current Ratio of 1.42 indicates that BNFT should not have too much problems paying its short term obligations.
BNFT has a Current ratio of 1.42. This is in the lower half of the industry: BNFT underperforms 60.13% of its industry peers.
BNFT has a Quick Ratio of 1.42. This is a normal value and indicates that BNFT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.42, BNFT is in line with its industry, outperforming 40.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.42
BNFT Yearly Current Assets VS Current LiabilitesBNFT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 116.67% over the past year.
The Revenue has decreased by -5.72% in the past year.
The Revenue has been growing slightly by 2.15% on average over the past years.
EPS 1Y (TTM)116.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.84%
Revenue 1Y (TTM)-5.72%
Revenue growth 3Y0.56%
Revenue growth 5Y2.15%
Sales Q2Q%-9.41%

3.2 Future

The Earnings Per Share is expected to grow by 117.19% on average over the next years. This is a very strong growth
Based on estimates for the next years, BNFT will show a small growth in Revenue. The Revenue will grow by 0.93% on average per year.
EPS Next Y180.75%
EPS Next 2Y105.18%
EPS Next 3Y117.19%
EPS Next 5YN/A
Revenue Next Year-2.12%
Revenue Next 2Y-0.22%
Revenue Next 3Y0.93%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BNFT Yearly Revenue VS EstimatesBNFT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
BNFT Yearly EPS VS EstimatesBNFT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1 -2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 350.00, which means the current valuation is very expensive for BNFT.
BNFT's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.04, BNFT is valued quite expensively.
Based on the Price/Forward Earnings ratio of 39.59, the valuation of BNFT can be described as expensive.
Based on the Price/Forward Earnings ratio, BNFT is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 37.64. BNFT is around the same levels.
Industry RankSector Rank
PE 350
Fwd PE 39.59
BNFT Price Earnings VS Forward Price EarningsBNFT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

81.40% of the companies in the same industry are more expensive than BNFT, based on the Enterprise Value to EBITDA ratio.
63.79% of the companies in the same industry are more expensive than BNFT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 202.47
EV/EBITDA 23.2
BNFT Per share dataBNFT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
BNFT's earnings are expected to grow with 117.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.94
PEG (5Y)N/A
EPS Next 2Y105.18%
EPS Next 3Y117.19%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BNFT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BENEFITFOCUS INC

NASDAQ:BNFT (1/23/2023, 8:12:24 PM)

After market: 10.5 0 (0%)

10.5

+0.01 (+0.1%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-07 2022-11-07/amc
Earnings (Next)02-27 2023-02-27/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners24.24%
Ins Owner Change0%
Market Cap361.42M
Analysts47.5
Price Target10.71 (2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-25.78%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.67%
Min EPS beat(2)17.92%
Max EPS beat(2)37.42%
EPS beat(4)4
Avg EPS beat(4)104.4%
Min EPS beat(4)17.92%
Max EPS beat(4)252.92%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.79%
Min Revenue beat(2)-1.87%
Max Revenue beat(2)-1.7%
Revenue beat(4)1
Avg Revenue beat(4)0.11%
Min Revenue beat(4)-1.87%
Max Revenue beat(4)5.18%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)31.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.23%
EPS NY rev (1m)0%
EPS NY rev (3m)-33.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 350
Fwd PE 39.59
P/S 1.45
P/FCF 202.47
P/OCF 29.57
P/B N/A
P/tB N/A
EV/EBITDA 23.2
EPS(TTM)0.03
EY0.29%
EPS(NY)0.27
Fwd EY2.53%
FCF(TTM)0.05
FCFY0.49%
OCF(TTM)0.36
OCFY3.38%
SpS7.24
BVpS-0.72
TBVpS-2.24
PEG (NY)1.94
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.35%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.18%
GM growth 5Y2.2%
F-Score3
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 65.75
Debt/EBITDA 6.43
Cap/Depr 39.3%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 1.42
Altman-Z -0.99
F-Score3
WACC10.98%
ROIC/WACCN/A
Cap/Depr(3y)52.55%
Cap/Depr(5y)52.42%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.84%
EPS Next Y180.75%
EPS Next 2Y105.18%
EPS Next 3Y117.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.72%
Revenue growth 3Y0.56%
Revenue growth 5Y2.15%
Sales Q2Q%-9.41%
Revenue Next Year-2.12%
Revenue Next 2Y-0.22%
Revenue Next 3Y0.93%
Revenue Next 5YN/A
EBIT growth 1Y-246.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year589.49%
EBIT Next 3Y111.48%
EBIT Next 5YN/A
FCF growth 1Y-53.27%
FCF growth 3Y215.77%
FCF growth 5YN/A
OCF growth 1Y-24.6%
OCF growth 3Y55.1%
OCF growth 5YN/A